Parallel Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $20M

  • Investors
  • 24

Parallel Bio General Information

Description

Developer of a drug development platform designed to evaluate the efficacy and safety of immunotherapies. The company's platform utilizes a framework combining human lymph-node immune organoids, automated robotics, and artificial intelligence, enabling medical professionals to conduct population-scale testing, model diverse patient backgrounds, and accelerate candidate drug pipelines without traditional animal testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1000 Marina Boulevard
  • Suite 105
  • Brisbane, CA 94005
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1000 Marina Boulevard
  • Suite 105
  • Brisbane, CA 94005
  • United States

Parallel Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parallel Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A1) 12-Jun-2025 $20M Completed Generating Revenue
3. Seed Round 20-Dec-2022 Completed Generating Revenue
2. Accelerator/Incubator 07-Jul-2021 $325K $325K Completed Startup
1. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Parallel Bio’s complete valuation and funding history, request access »

Parallel Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-4
Series A-3 439,752 $0.000100 8% $0.45 $0.45 1x $0.45 1.57%
Series A-2 1,231,342 $0.000100 8% $0.1 $0.1 1x $0.1 4.38%
To view Parallel Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Parallel Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug development platform designed to evaluate the efficacy and safety of immunotherapies. The company's
Drug Discovery
Brisbane, CA
27 As of 2026

San Diego, CA
 

Thousand Oaks, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parallel Bio Competitors (2)

One of Parallel Bio’s 2 competitors is ImmunityBio, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunityBio Formerly VC-backed San Diego, CA
Atara Biotherapeutics Formerly VC-backed Thousand Oaks, CA
You’re viewing 2 of 2 competitors. Get the full list »

Parallel Bio Patents

Parallel Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025155725-A1 Methods of using immune organoids to predict drug efficacy Pending 17-Jan-2024
WO-2025155727-A1 Methods of using immune organoids to predict drug safety Pending 17-Jan-2024
US-11913967-B2 System and method for determining dispensing volume for a liquid handler Active 22-Jul-2022
US-12265097-B2 System and method for determining dispensing volume for a liquid handler Active 22-Jul-2022
US-20240027486-A1 System and method for determining dispensing volume for a liquid handler Active 22-Jul-2022 G01N35/1016
To view Parallel Bio’s complete patent history, request access »

Parallel Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parallel Bio Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIX Ventures Venture Capital Minority
Amplo Venture Capital Minority
Autopilot Fund Venture Capital Minority
Angel (individual) Minority
10X Capital Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Parallel Bio FAQs

  • When was Parallel Bio founded?

    Parallel Bio was founded in 2021.

  • Where is Parallel Bio headquartered?

    Parallel Bio is headquartered in Brisbane, CA.

  • What is the size of Parallel Bio?

    Parallel Bio has 27 total employees.

  • What industry is Parallel Bio in?

    Parallel Bio’s primary industry is Drug Discovery.

  • Is Parallel Bio a private or public company?

    Parallel Bio is a Private company.

  • What is the current valuation of Parallel Bio?

    The current valuation of Parallel Bio is .

  • What is Parallel Bio’s current revenue?

    The current revenue for Parallel Bio is .

  • How much funding has Parallel Bio raised over time?

    Parallel Bio has raised $24.6M.

  • Who are Parallel Bio’s investors?

    AIX Ventures, Amplo, Autopilot Fund, , and 10X Capital are 5 of 24 investors who have invested in Parallel Bio.

  • Who are Parallel Bio’s competitors?

    ImmunityBio and Atara Biotherapeutics are competitors of Parallel Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process